The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial

被引：0
|
作者：
Mary Ni Lochlainn
Ayrun Nessa
Alyce Sheedy
Rachel Horsfall
María Paz García
Deborah Hart
Gulsah Akdag
Darioush Yarand
Samuel Wadge
Andrei-Florin Baleanu
Kevin Whelan
Claire Steves
机构：
[1] King’s College London,Department of Twin Research & Genetic Epidemiology
[2] King’s College London,Department of Nutritional Sciences
来源：
BMC Geriatrics | / 21卷
关键词：
Ageing; Sarcopenia; Gut microbiome; Anabolic resistance; Muscle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
    Lochlainn, Mary Ni
    Nessa, Ayrun
    Sheedy, Alyce
    Horsfall, Rachel
    Garcia, Maria Paz
    Hart, Deborah
    Akdag, Gulsah
    Yarand, Darioush
    Wadge, Samuel
    Baleanu, Andrei-Florin
    Whelan, Kevin
    Steves, Claire
    BMC GERIATRICS, 2021, 21 (01)
  • [2] Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol
    Hanssen, Hege Marie
    Fjellstad, Maria Serafia
    Skjevling, Linn
    Johnsen, Peter Holger
    Kulseng, Bard
    Goll, Rasmus
    Alma, Kristin Helen
    Valle, Per-Christian
    BMJ OPEN, 2023, 13 (12):
  • [3] Estimation of treatment allocation in a randomised, double-blinded, placebo-controlled trial
    Milica, Popovic
    Nicole, Cesana-Nigro
    Bettina, Winzeler
    Robert, Thomann
    Philipp, Schutz
    Beat, Mueller
    Mirjam, Christ-Crain
    Claudine, Blum A.
    SWISS MEDICAL WEEKLY, 2019, 149
  • [4] Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial
    Thomas Lillicrap
    Venkatesh Krishnamurthy
    John Attia
    Michael Nilsson
    Christopher R. Levi
    Mark W. Parsons
    Andrew Bivard
    Trials, 17
  • [5] Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial
    Lillicrap, Thomas
    Krishnamurthy, Venkatesh
    Attia, John
    Nilsson, Michael
    Levi, Christopher R.
    Parsons, Mark W.
    Bivard, Andrew
    TRIALS, 2016, 17
  • [6] Optimising the treatment for uncomplicated acute appendicitis (OPTIMA trial): a protocol for a multicentre, randomised, double-blinded placebo-controlled study
    Wu, Jie
    Jiang, Haiyang
    Li, Shikuan
    Wu, Xiuwen
    Wang, Peige
    Sawyer, Robert
    Ren, Jianan
    BMJ OPEN, 2022, 12 (05):
  • [7] Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial
    Wolff, Birte J.
    Price, Travis K.
    Joyce, Cara J.
    Wolfe, Alan J.
    Mueller, Elizabeth R.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (12) : 2149 - 2159
  • [8] Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial
    Birte J. Wolff
    Travis K. Price
    Cara J. Joyce
    Alan J. Wolfe
    Elizabeth R. Mueller
    International Urology and Nephrology, 2019, 51 : 2149 - 2159
  • [9] Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial
    Tan, Lu
    Furian, Michael
    Li, Taomei
    Tang, Xiangdong
    BMJ OPEN, 2022, 12 (03):
  • [10] The effect of ketorolac on posterior thoracolumbar spinal fusions: a prospective double-blinded randomised placebo-controlled trial protocol
    Claus, Chad F.
    Lytle, Evan
    Tong, Doris
    Sigler, Diana
    Lago, Dominick
    Bahoura, Matthew
    Dosanjh, Amarpal
    Lawless, Michael
    Slavnic, Dejan
    Kelkar, Prashant
    Houseman, Clifford
    Bono, Peter
    Richards, Boyd
    Soo, Teck M.
    BMJ OPEN, 2019, 9 (01):
12345